Role of the NUDT Enzymes in Breast Cancer
Despite global research efforts, breast cancer remains the leading cause of cancer death in women worldwide. The majority of these deaths are due to metastasis occurring years after the initial treatment of the primary tumor and occurs at a higher frequency in hormone receptor-positive (Estrogen and...
Main Authors: | Roni H. G. Wright, Miguel Beato |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/5/2267 |
Similar Items
-
Moving beyond PARP Inhibition: Current State and Future Perspectives in Breast Cancer
by: Michela Palleschi, et al.
Published: (2021-07-01) -
In silico Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization
by: Maurice Michel, et al.
Published: (2020-05-01) -
PARP Inhibitors in the Treatment of Early Breast Cancer: The Step Beyond?
by: Anthony Gonçalves, et al.
Published: (2020-05-01) -
HEREDITARY BREAST CANCER
by: E. M. Bit-Sava, et al.
Published: (2016-02-01) -
Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
by: Alicja Urbaniak, et al.
Published: (2021-09-01)